Literature DB >> 22126377

Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application.

Suguru Yonezawa1, Michiyo Higashi, Norishige Yamada, Seiya Yokoyama, Sho Kitamoto, Shinichi Kitajima, Masamichi Goto.   

Abstract

Mucins are high molecular weight glycoproteins that play important roles in carcinogenesis and tumor invasion. Our immunohistochemical studies demonstrated that MUC1 or MUC4 expression is related to the aggressive behavior and poor outcome of human neoplasms. MUC2 is expressed in indolent pancreatobiliary neoplasms, but these tumors sometimes show invasive growth with MUC1 expression in invasive areas. MUC5AC shows de novo high expression in many types of precancerous lesions of pancreatobiliary cancers and is an effective marker for early detection of the neoplasms. The combination of MUC1, MUC2, MUC4 and MUC5AC expression may be useful for early detection and evaluation of the potential for malignancy of pancreatobiliary neoplasms. Regarding the mechanism of mucin expression, we have recently reported that expression of the mucin genes is regulated epigenetically in cancer cell lines, using quantitative MassARRAY analysis, methylation-specific polymerase chain reaction analysis and chromatin immunoprecipitation analysis, with confirmation by the treatment with 5-aza-2'-deoxycytidine and trichostatin A. We have also developed a monoclonal antibody against the MUC1 cytoplasmic tail domain, which has many biological roles. Based on all of the above findings, we suggest that translational research into mucin gene expression mechanisms, including epigenetics, may provide new tools for early and accurate detection of human neoplasms.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126377     DOI: 10.1111/j.1440-1827.2011.02734.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  44 in total

1.  Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Michiyo Higashi; Seiya Yokoyama; Takafumi Yamamoto; Yuko Goto; Ikumi Kitazono; Tsubasa Hiraki; Hiroki Taguchi; Shinichi Hashimoto; Yoshihiko Fukukura; Chihaya Koriyama; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Maneesh Jain; Surinder K Batra; Suguru Yonezawa
Journal:  Pancreas       Date:  2015-07       Impact factor: 3.327

2.  Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer.

Authors:  Koji Teramoto; Yoshitomo Ozaki; Jun Hanaoka; Satoru Sawai; Noriaki Tezuka; Shozo Fujino; Yataro Daigo; Keiichi Kontani
Journal:  Ther Adv Med Oncol       Date:  2016-11-24       Impact factor: 8.168

3.  Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets.

Authors:  Nalin C W Goonesekere; Wyatt Andersen; Alex Smith; Xiaosheng Wang
Journal:  J Cancer Res Clin Oncol       Date:  2017-12-29       Impact factor: 4.553

4.  Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.

Authors:  Yoshiaki Kamikawa; Yuji Kanmura; Tomofumi Hamada; Norishige Yamada; Muzafar A Macha; Surinder K Batra; Michiyo Higashi; Suguru Yonezawa; Kazumasa Sugihara
Journal:  Int J Clin Oncol       Date:  2014-06-10       Impact factor: 3.402

5.  Aberrant expression of CD227 is correlated with tumor characteristics and invasiveness of breast carcinoma.

Authors:  Ya-Wen Wang; Duan-Bo Shi; Ya-Min Liu; Yan-Lin Sun; Xu Chen; Shuai Xiang; Qiang Fu; Jun-Min Wei; Peng Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-01       Impact factor: 4.553

6.  Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.

Authors:  Yuki Fukumura; Yasuni Nakanuma; Yuko Kakuda; Masaru Takase; Takashi Yao
Journal:  Virchows Arch       Date:  2017-05-26       Impact factor: 4.064

Review 7.  Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2013-02-28

Review 8.  Prostate cancer relevant antigens and enzymes for targeted drug delivery.

Authors:  Ashutosh Barve; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

9.  Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.

Authors:  Paola Marcato; Cheryl A Dean; Rong-Zong Liu; Krysta M Coyle; Moamen Bydoun; Melissa Wallace; Derek Clements; Colin Turner; Edward G Mathenge; Shashi A Gujar; Carman A Giacomantonio; John R Mackey; Roseline Godbout; Patrick W K Lee
Journal:  Mol Oncol       Date:  2014-07-24       Impact factor: 6.603

10.  Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Iwao Kitazono; Michiyo Higashi; Sho Kitamoto; Seiya Yokoyama; Michiko Horinouchi; Masahiko Osako; Takeshi Shimizu; Mineo Tabata; Surinder K Batra; Masamichi Goto; Suguru Yonezawa
Journal:  Pancreas       Date:  2013-10       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.